Skp2B Overexpression Affects p53 and PAPP-A in Breast Cancer
Author Information
Author(s): Chander Harish, Halpern Max, Resnick-Silverman Lois, Manfredi James J., Germain Doris
Primary Institution: Mount Sinai School of Medicine, New York, New York, United States of America
Hypothesis
Is there a link between p53 activity and the proteolysis of IGFBP-4 in breast cancer?
Conclusion
The study reveals that prohibitin acts as a chaperone for p53, and its degradation by Skp2B leads to increased PAPP-A levels and IGFBP-4 cleavage, contributing to breast cancer progression.
Supporting Evidence
- Skp2B overexpression leads to increased levels of PAPP-A.
- Wild type p53 represses PAPP-A transcription, while mutant p53 activates it.
- Prohibitin is necessary for maintaining the proper conformation of p53.
Takeaway
When a protein called prohibitin is reduced, another protein called p53 can get messed up, which leads to changes that can cause breast cancer.
Methodology
The study used transgenic mice and various cell lines to analyze the effects of Skp2B overexpression on p53 and PAPP-A levels.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website